Channelopathies
Channelopathies
Explore linked clinical trials. Standard reference: MESH:M04931435 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Physical Activity and Functional Capacity in Patients With Congenital Long QT Syndrome | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Abnormalities, Channelopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, congenital heart disease, heart disorder | Not yet recruiting | Not stated | 2026-10-07 | NCT07862491 | |
| Aprepitant for the Treatment of CLIFAHDD | Channelopathies, Disease Attributes, Dyskinesias, Facies, Muscle Hypotonia, Neurobehavioral Manifestations, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atactic disorder, non-human animal, communication disorder, congenital contractures of the limbs and face, hypotonia, and developmental delay, disease, learning disability, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Recruiting | Early phase 1 | 2026-10-05 | NCT07845825 | |
| A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia | Channelopathies, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, erythromelalgia, generalized epilepsy with febrile seizures plus, type 7, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder, peripheral vascular disease, primary erythermalgia, vascular disorder | Enrolling by invitation | Phase 1 | 2026-04-08 | NCT07262268 | |
| Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias | Arrhythmias, Cardiac, Brugada syndrome, Cardiac Conduction System Disease, Cardiomegaly, Cardiovascular Abnormalities, Channelopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polymorphic Catecholaminergic Ventricular Tachycardia, Tachycardia, X-linked disease, aortic valve disorder, aortic valve stenosis, arrhythmogenic right ventricular cardiomyopathy, cardiomyopathy, cardiovascular disorder, congenital heart disease, dilated cardiomyopathy, heart disorder, heart valve disorder, hereditary disease, hypertrophic cardiomyopathy, inherited neurodegenerative disorder, laminopathy, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease, subvalvular aortic stenosis, ventricular tachycardia | Enrolling by invitation | Not stated | 2026-01-16 | NCT02413450 | |
| Genetic Markers of Cardiovascular Disease in Epilepsy | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Abnormalities, Channelopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Consciousness Disorders, Death, Death, Sudden, Death, Sudden, Cardiac, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polymorphic Catecholaminergic Ventricular Tachycardia, Signs and Symptoms, Sudden Unexpected Death in Epilepsy, Syncope, Tachycardia, Unconsciousness, brain disorder, cardiac arrest, cardiomyopathy, cardiovascular disorder, central nervous system disorder, congenital heart disease, epilepsy, heart disorder, nervous system disorder, ventricular tachycardia, visual epilepsy | Recruiting | Not stated | 2025-09-08 | NCT02824822 |